Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
| Distributed by / for | RLC Labs Inc. |
| NDC | 64727-3303-4 |
| Full product label | Nature-Throid, Thyroid USP [liothyronine (T3) 11.25 mcg and levothyroxine (T4) 47.5 mcg], 1.25 Grain (81.25 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3303-4; b) 60-count bottles, NDC 64727-3303-5; c) 90-count bottles, NDC 64727-3303-6; d) 100-count bottles, NDC 64727-3303-1; e) 1,000-count bottles, NDC 64727-3303-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034. |
| Recalling firm | RLC Labs Inc. |
| Distribution | Nationwide in the United States |
| Quantity | N/A |
| Recall initiated | 2020-08-25 |
| Report date | 2020-09-23 |
| Recall completed | 2023-11-08 |
| Recall number | D-1599-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Phoenix AZ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗